<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6926871/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Degree of success, limitations and concomitant effects of entry and exit screening at points of entry for Severe Acute Respiratory Syndrome (SARS), Influenza Pandemic (H1N1) 2009 (A(H1N1)pdm09) and Ebola Virus Disease (EVD).</p>
 </caption>
 <thead>
  <tr>
   <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1" id="0-0-B-a">Degree of Success in Identifying Ill or Exposed Travelers</th>
   <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1" id="0-1-B-a">Limitations</th>
   <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" id="0-2-b">Concomitant Effects</th>
  </tr>
  <tr>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" id="1-2-.">Beneficial</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" id="1-3-.">Adverse</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <b>
     <u>Influenza A(H1N1)pdm09</u>
     <sup>˅</sup> [ 
     <a rid="B20-ijerph-16-04638" ref-type="bibr">20</a>, 
     <a rid="B21-ijerph-16-04638" ref-type="bibr">21</a>] 
    </b>
    <br/>
    <b>Sensitivity: 6.67% (95% CI, 1.40%–18.27%)</b>
    <br/>
    <b>Specificity: 99.10% (95% CI, 99.00%–100.00%)</b>
    <br/>  
    <br/>
    <b>
     <u>EVD </u>
     <sup>˄</sup> [ 
     <a rid="B22-ijerph-16-04638" ref-type="bibr">22</a>] 
    </b>
    <br/>
    <b>Sensitivity: 0%</b>
    <br/>
    <b>Specificity: 99.79%</b>
    <br/>  
    <br/>
    <b>
     <u>SARS </u>
     <sup>˅</sup> [ 
     <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>, 
     <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>, 
     <a rid="B13-ijerph-16-04638" ref-type="bibr">13</a>, 
     <a rid="B23-ijerph-16-04638" ref-type="bibr">23</a>] 
    </b>
    <br/>
    <b>Entry screening measures did not detect any confirmed SARS cases in Australia, Canada, and Singapore.</b>
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <u>Influenza A(H1N1)pdm09</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>Screening cannot detect incubating or asymptomatic travelers 
       <sup>˅</sup> I [ 
       <a rid="B24-ijerph-16-04638" ref-type="bibr">24</a>] 
      </p>
     </li>
    </ul>
    <u>SARS</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>False declarations by passengers about exposure and disease signs and symptoms 
       <sup>˅</sup> S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Antipyretic drugs can be used by travelers to conceal fever 
       <sup>˅</sup> S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Questionnaires asking about exposure and thermal scanning machines, were non-specific for SARS 
       <sup>˅</sup> S [ 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>The frequency of SARS among international passengers arriving or departing was low resulting in low positive predictive value 
       <sup>˅</sup> S [ 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>The de facto point of entry into the healthcare system for travelers with serious infectious diseases was found to be the in-country, acute care facilities (hospitals, clinics, and physicians’ offices) and not the airports 
       <sup>˅</sup> S [ 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Language barriers—flight announcements about screening measures and requests for declaring exposures were not understood by passengers 
       <sup>˅</sup> S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Exit screening measures may have not dissuading ill travelers from attempting to return home 
       <sup>‡</sup> S [ 
       <a rid="B25-ijerph-16-04638" ref-type="bibr">25</a>] 
      </p>
     </li>
    </ul>
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <u>Influenza A(H1N1)pdm09 and EVD</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>Obtaining contact information of travelers to be used if needed for contact tracing or public health observation purposes 
       <sup>˅</sup> E,I [ 
       <a rid="B6-ijerph-16-04638" ref-type="bibr">6</a>, 
       <a rid="B26-ijerph-16-04638" ref-type="bibr">26</a>] 
      </p>
     </li>
    </ul>
    <br/>
    <u>EVD</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>Educating and informing the traveler passing through the screening points about the public health risks and prevention measures 
       <sup>˅</sup> E [ 
       <a rid="B6-ijerph-16-04638" ref-type="bibr">6</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Linking the traveler with public health authorities for the duration of the incubation period to facilitate health monitoring and prompt referral for care if they became ill 
       <sup>˅</sup> E [ 
       <a rid="B6-ijerph-16-04638" ref-type="bibr">6</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Facilitating rapid and appropriate clinical care for ill travelers 
       <sup>‡</sup> E [ 
       <a rid="B6-ijerph-16-04638" ref-type="bibr">6</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Maintaining confidence that air travel is safe 
       <sup>˅</sup> E [ 
       <a rid="B6-ijerph-16-04638" ref-type="bibr">6</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Enabling humanitarian and public health organizations to sustain travel to affected areas by regular commercial airline flights, maintaining continued flow of passenger traffic and resources needed for the response to the affected region 
       <sup>˄</sup> E [ 
       <a rid="B16-ijerph-16-04638" ref-type="bibr">16</a>, 
       <a rid="B27-ijerph-16-04638" ref-type="bibr">27</a>, 
       <a rid="B28-ijerph-16-04638" ref-type="bibr">28</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>In EVD-affected countries, laid the foundation for future reconstruction efforts related to borders and travel, including IHR core capacities (e.g., regional surveillance systems, cross-border coordination) 
       <sup>˄</sup> E [ 
       <a rid="B16-ijerph-16-04638" ref-type="bibr">16</a>] 
      </p>
     </li>
    </ul>
    <br/>
    <u>SARS</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>May have helped dissuade ill persons from traveling by air 
       <sup>‡</sup> S [ 
       <a rid="B25-ijerph-16-04638" ref-type="bibr">25</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Preserving public confidence ˅S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>, 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>, 
       <a rid="B29-ijerph-16-04638" ref-type="bibr">29</a>], relieving political and social pressure and limiting negative economic consequences from travel and trade restrictions 
       <sup>˅</sup> S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Help avoiding major economic, social and international impact which even a single imported SARS case may have 
       <sup>˅</sup> S [ 
       <a rid="B23-ijerph-16-04638" ref-type="bibr">23</a>] 
      </p>
     </li>
    </ul>
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <u>EVD</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>May give to the public a false sense of security 
       <sup>˅</sup> E [ 
       <a rid="B30-ijerph-16-04638" ref-type="bibr">30</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Stigmatization of travelers under public health observation 
       <sup>˅</sup> E [ 
       <a rid="B31-ijerph-16-04638" ref-type="bibr">31</a>] 
      </p>
     </li>
    </ul>
    <u>SARS</u>
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">∙</p>
      <p>High cost of screening measures 
       <sup>˅</sup> S [ 
       <a rid="B8-ijerph-16-04638" ref-type="bibr">8</a>, 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>, 
       <a rid="B13-ijerph-16-04638" ref-type="bibr">13</a>] 
      </p>
     </li>
     <li class="list-item">
      <p class="label">∙</p>
      <p>Investing in screening measures reduces the resources from other effective measures 
       <sup>˅</sup> S [ 
       <a rid="B9-ijerph-16-04638" ref-type="bibr">9</a>, 
       <a rid="B23-ijerph-16-04638" ref-type="bibr">23</a>] 
      </p>
     </li>
    </ul>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>
    <sup>˄</sup>: Exit screening, 
    <sup>‡</sup>: Entry and Exit screening, 
    <sup>˅</sup>: Entry screening “S”: Severe Acute Respiratory Syndrome (SARS),”I”: 2009 Influenza Pandemic (H1N1) (influenza A(H1N1)pdm09), “E”: Ebola Virus Disease (EVD). 
   </p>
  </p>
 </tfoot>
</table>
